May 2004
Volume 45, Issue 13
ARVO Annual Meeting Abstract  |   May 2004
Clinical manifestations in Mexican patients with Wegener's granulomatosis
Author Affiliations & Notes
  • D. De los Rios
    I.N.C.M.N.S.Z., D.f., Mexico
  • L. Flores–Suarez
    Immunology and Rheumatology,
    I.N.C.M.N.S.Z., D.f., Mexico
  • L. Arellanes
    Ocular Inflammatory Diseases, A.P.E.C., D.f., Mexico
  • Footnotes
    Commercial Relationships  D. De los Rios, None; L. Flores–Suarez, None; L. Arellanes, None.
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 2715. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      D. De los Rios, L. Flores–Suarez, L. Arellanes; Clinical manifestations in Mexican patients with Wegener's granulomatosis . Invest. Ophthalmol. Vis. Sci. 2004;45(13):2715.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Abstract: : Purpose: To describe the most frequent clinical manifestations in Mexican patients with Wegener's granulomatosis (WG) Methods: Retrospective study wich included all patients with diagnosis of WG seen the last two years in two institutions. Results: We reviewed the charts of 39 patients. Mean age was 43 years, 26 males and 13 women. Initial symptoms were extraocular in 15 patients, ocular in 9 and mixed in 15. Initial ocular findings were eye redness 63%, scleromalacia 48%, necrotizing scleritis 41%, peripheric ulcerative keratitis 41% and difuse scleritis 33%. Conclusions:WG is a autoimmune systemic disease with frequent severe anterior segment alterations as initial symptoms of the disease.

Keywords: clinical (human) or epidemiologic studies: natural history • sclera • autoimmune disease 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.